NasdaqGS:IDXXMedical Equipment
Idexx Laboratories (IDXX) Margin Strength Reinforces Bullish Narrative Despite Premium P/E
IDEXX Laboratories (IDXX) has just wrapped up FY 2025 with fourth quarter revenue of US$1,090.6 million and basic EPS of US$3.11, alongside trailing twelve month revenue of US$4.3 billion and EPS of US$13.17 that frame the latest print against a fuller year of performance. Over recent quarters the company has seen revenue move from US$954.3 million in Q4 2024 to just above US$1.1 billion in Q2 and Q3 2025, while quarterly EPS stepped from US$2.64 to a range between roughly US$3.0 and US$3.66,...